Trial Profile
The efficacy and tolerability of enfuvirtide + saquinavir + efavirenz + ritonavir versus saquinavir + efavirenz + ritonavir in antiretroviral-inexperienced patients with HIV infections
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2010
Price :
$35
*
At a glance
- Drugs Enfuvirtide (Primary) ; Saquinavir (Primary) ; Efavirenz; Ritonavir
- Indications HIV infections
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.